过去一年中添加的文章，按日期排序
Dacomitinib exhibits promising activity against the rare HER2 exon 20 insertion M774delinsWLV in lung cancer: A case report and literature review
G Yang, R Liu, X Tang - Heliyon, 2024 - cell.com
57 天前 - … Herein, we presented a case of non-small cell lung cancer harboring
M774delinsWLV who derived favorable response and significant survival benefit from HER2-targeted …
M774delinsWLV who derived favorable response and significant survival benefit from HER2-targeted …
Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study
X Pu, Y Zhou, Y Kong, B Chen, A Yang, J Li, K Li, Y Xu… - Bmc Cancer, 2023 - Springer
250 天前 - … Approximately 85% of all lung cancers are non-small cell lung cancer (NSCLC) [2].In …
applied to evaluate treatment response before and during dacomitinib treatment. Target …
applied to evaluate treatment response before and during dacomitinib treatment. Target …
[HTML][HTML] … with non-small cell lung cancer carrying uncommon EGFR mutations, HER2 mutations, or brain metastases: a systematic review of pre-clinical and clinical …
LL Yang, XZ Luo, LL Xie, XZ Lei… - Translational Cancer …, 2023 - ncbi.nlm.nih.gov
319 天前 - … review intends to give a comprehensive summary on potential applications of
dacomitinib … and HER2) or CNS metastases, hoping to be helpful for clinicians’ decision-making. …
dacomitinib … and HER2) or CNS metastases, hoping to be helpful for clinicians’ decision-making. …